New dose estimation methods and their application in early drug discovery using intravenous, oral and inhaled routes of administration for new chemical entities
1 of 10
Design and synthesis of dimethylisoxazole quinolines as BET inhibitors
2 of 10
The development of chemo- and regioselective reactions of boron systems
3 of 10
New chemical approaches for the development of targeted protein degradation
4 of 10
Targeted protein degradation as a new approach to drug discovery
5 of 10
Novel biocatalytic strategies for the synthesis of N-functionalised amino acids
6 of 10
Development of lysine-targeted irreversible inhibitors of PI3Kδ
7 of 10
The design and synthesis of αvβ6 antagonists and PI3K inhibitors as small molecule therapies for respiratory diseases
8 of 10
Novel PI3Kδ inhibitors for the treatment of inflammatory diseases
9 of 10
Use of fragment-based drug discovery to identify novel drug molecules for challenging biological targets, including protein-protein interactions